Wuillemin notes 20 years of experience with self-administration in Switzerland. Indeed, Switzerland has led the way in this area, with excellent training and support for patients. Elsewhere in Europe, progress has been slower. Gompels and colleagues reviewed the situation in the United Kingdom and offered clear requirements for possession and self-administration of C1 inhibitor, 1 including moderate-to-severe disease requiring C1 inhibitor infusion at least every 3 months, the availability of support from a partner when therapy is administered, successful completion of a comprehensive training program, good venous access, and agreement of the patient's general practitioner. Many patients, including children, will be excluded by these sensible guidelines. Practitioners fear that drug use will escalate as patients treat minor swellings or false prodromes, increasing costs and perhaps also the risk of drug reactions. The Swiss experience might provide reassurance about these matters, and available data should be disseminated.
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Determinants of Lung Function, COPD, and Asthma
To the Editor: In a genomewide association study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, we identified several loci as genetic determinants of spirometric measures of lung function in more than 20,000 adults from population-based cohorts. 1 Moffatt et al. (Sept. 23 issue) 2 attributed to us the statement that "genetic determinants of lung function influence susceptibility to asthma" and indicated that their own data "do not support this hypothesis." Because chronic obstructive pulmonary disease (COPD) is defined on the basis of the same spirometric measures of lung function, it is not surprising that some loci associated with measurements of lung function are also associated with COPDfor example, loci containing HHIP and FAM13A. 3, 4 We would not necessarily expect to observe associations between these same loci and asthma. We found that genetic associations with lung function were generally unchanged, despite the reduction in power brought about by excluding persons with asthma or COPD from the analysis. 1 We interpreted this finding as evidence that many of the implicated loci are determinants of lung function in the general population. No potential conflict of interest relevant to this letter was reported. To the Editor: As in Scotland, the passage of smoke-free legislation in 2005 was associated with a reduction in the rate of hospitalizations for childhood asthma in the Lombardy region of Italy. We observed a decrease of 30.7% (95% confidence interval, 22.8 to 38.6) in the rate of admissions for asthma; a total of 15,042 children were hospitalized for asthma during the study period (Table 1) . We speculate that the law may have had a positive influence on parental smoking, reducing in-home smoking and consequently passive exposure to tobacco smoke. However,
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